KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for Resmed (RMD) over the last 14 years, with Q4 2025 value amounting to $87.6 million.

  • Resmed's Dividends Paid - Common rose 1272.8% to $87.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $330.6 million, marking a year-over-year increase of 1146.1%. This contributed to the annual value of $310.9 million for FY2025, which is 1011.62% up from last year.
  • Per Resmed's latest filing, its Dividends Paid - Common stood at $87.6 million for Q4 2025, which was up 1272.8% from $87.8 million recorded in Q3 2025.
  • Resmed's 5-year Dividends Paid - Common high stood at $87.8 million for Q3 2025, and its period low was $56.8 million during Q1 2021.
  • Moreover, its 5-year median value for Dividends Paid - Common was $67.6 million (2023), whereas its average is $69.3 million.
  • Its Dividends Paid - Common has fluctuated over the past 5 years, first skyrocketed by 55.41% in 2021, then soared by 1272.8% in 2025.
  • Resmed's Dividends Paid - Common (Quarter) stood at $61.2 million in 2021, then rose by 5.31% to $64.5 million in 2022, then increased by 9.58% to $70.7 million in 2023, then increased by 9.93% to $77.7 million in 2024, then grew by 12.73% to $87.6 million in 2025.
  • Its Dividends Paid - Common stands at $87.6 million for Q4 2025, versus $87.8 million for Q3 2025 and $77.6 million for Q2 2025.